Public policy engagement is an important and appropriate role for private sector companies. At Celgene, we believe it is essential to work with public policymakers to help ensure that the policy environment is supportive of patient access to life-changing medicines and enhances the promise of medical innovation. Our public policy advocacy reflects our commitment to improving the lives of patients and advancing the course of human health through innovation and bold pursuits of science.

Government policies directly impact patient access and medical innovation. Given the potential impact of policy change on patients and our mission, we actively participate in public policy discussions to share our perspectives and experience as an innovative biopharmaceutical company committed to advancing therapies for patients with unmet medical needs.

	Celgene Public Policy Priorities Celgene champions legislation that promotes fair insurance benefit design, preserves patients’ access to the therapies their doctors prescribe, and places appropriate limits on out-of-pocket costs for specialty medicines. Learn more
	Association Memberships Celgene is a member of a number of associations that represent the biopharmaceutical sector and the business community in general. Learn more
	Political Contributions Information on Celgene PAC and Political Contributions Governance and Transparency, and our Political Contributions Reports. Learn more